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Abstract
Introduction:  There  are  several  risk  scores  for  stratiﬁcation  of  patients  with  ST-segment  ele-
vation myocardial  infarction  (STEMI),  the  most  widely  used  of  which  are  the  TIMI  and  GRACE
scores. However,  these  are  complex  and  require  several  variables.  The  aim  of  this  study  was  to
obtain a  reduced  model  with  fewer  variables  and  similar  predictive  and  discriminative  ability.
Methods:  We  studied  607  patients  (age  62  years,  SD=13;  76%  male)  who  were  admitted  with
STEMI and  underwent  successful  primary  angioplasty.  Our  endpoints  were  all-cause  in-hospital
and 30-day  mortality.  Considering  all  variables  from  the  TIMI  and  GRACE  risk  scores,  multivariate
logistic regression  models  were  ﬁtted  to  the  data  to  identify  the  variables  that  best  predicted
death.
Results: Compared  to  the  TIMI  score,  the  GRACE  score  had  better  predictive  and  discriminative
performance  for  in-hospital  mortality,  with  similar  results  for  30-day  mortality.  After  data  mod-
eling, the  variables  with  highest  predictive  ability  were  age,  serum  creatinine,  heart  failure
and the  occurrence  of  cardiac  arrest.  The  new  predictive  model  was  compared  with  the  GRACE
risk score,  after  internal  validation  using  10-fold  cross  validation.  A  similar  discriminative  per-
formance was  obtained  and  some  improvement  was  achieved  in  estimates  of  probabilities  of
death (increased  for  patients  who  died  and  decreased  for  those  who  did  not).
Conclusion:  It  is  possible  to  simplify  risk  stratiﬁcation  scores  for  STEMI  and  primary  angioplasty
loaded from http://www.elsevier.pt, day 16/04/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.using only  four  variables  (age,  serum  creatinine,  heart  failure  and  cardiac  arrest).  This  simpliﬁed
model maintained  a  good  predictive  and  discriminative  performance  for  short-term  mortality.
© 2012  Sociedade  Portuguesa  de  Cardiologia.  Published  by  Elsevier  España,  S.L.  All  rights
reserved.
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Será  possível  simpliﬁcar  os  scores  de  estratiﬁcac¸ão de  risco  em  doentes  com  enfarte
agudo  do  miocárdio  submetidos  a  angioplastia  primária?
Resumo
Introduc¸ão:  Existem  vários  scores  para  estratiﬁcac¸ão  de  risco  em  doentes  com  enfarte  agudo
miocárdico  com  elevac¸ão  segmento  ST  (EAMCEST),  sendo  os  mais  utilizados  o  TIMI  e  o  GRACE.
Contudo,  são  complexos  e  necessitam  de  várias  variáveis  para  o  seu  cálculo.  Este  estudo  teve
como objetivo  encontrar  um  modelo  de  predic¸ão  de  risco,  com  menos  variáveis  e  idêntica
capacidade  preditiva/discriminativa.
Métodos:  Estudaram-se  607  doentes  (62  anos,  SD=13;  76%  sexo  masculino),  admitidos  por  EAM-
CEST e  submetidos  a  angioplastia  primária  com  sucesso.  Consideraram-se  como  outcomes,  a
mortalidade  intra-hospitalar  e  aos  30  dias  de  seguimento.  Para  identiﬁcar  quais  das  variáveis
dos referidos  scores  se  revelaram  mais  inﬂuentes  na  previsão  da  mortalidade,  foram  efetuadas
análises de  regressão  logística.
Resultados:  Dos  dois  scores  clássicos,  o  GRACE  foi  o  que  apresentou  melhor  capacidade
preditiva/discriminativa  para  a  mortalidade  intra-hospitalar,  com  resultados  semelhantes  para
a mortalidade  aos  30  dias.  Na  construc¸ão  do  modelo  reduzido,  as  variáveis  selecionadas  foram
a idade,  a  creatinina,  a  insuﬁciência  cardíaca  e  a  paragem  cardíaca.  As  estimativas  das
probabilidades  de  morte  intra-hospitalar,  obtidas  através  de  validac¸ão  cruzada,  foram  com-
paradas com  as  do  modelo  original  do  score  GRACE.  As  capacidades  discriminativas  foram
idênticas  tendo  ainda  sido  obtida  alguma  melhoria  nas  estimativas  das  probabilidades  de  morte
(aumento/diminuic¸ão para  os  doentes  que  morreram/não  morreram).
Conclusões:  É  possível  uma  simpliﬁcac¸ão  dos  scores  de  estratiﬁcac¸ão  de  risco  para  EAMCEST  e
angioplastia  primária  com  apenas  as  variáveis  idade,  creatinina,  insuﬁciência  cardíaca  e  para-
gem cardíaca.  O  modelo  simpliﬁcado  manteve  um  bom  desempenho  preditivo/discriminativo
para a  mortalidade  a  curto-prazo.
© 2012  Sociedade  Portuguesa  de  Cardiologia.  Publicado  por  Elsevier  España,  S.L.  Todos  os
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List  of  abbreviations
ACEI  angiotensin-converting  enzyme  inhibitor
ACS  acute  coronary  syndrome
AUC  area  under  the  curve
CABG  coronary  artery  bypass  grafting
CI  conﬁdence  interval
GRACE  Global  Registry  of  Acute  Coronary  Events
HL  Hosmer-Lemeshow
ICU  intensive  care  unit
IDI  integrated  discrimination  improvement
NRI  net  reclassiﬁcation  improvement
OR  odds  ratio
PCI  percutaneous  coronary  intervention
ROC  receiver  operating  characteristic
SD  standard  deviation
STEMI  ST-elevation  myocardial  infarction
TIMI  Thrombolysis  In  Myocardial  Infarction
ntroduction
atients  with  ST-segment  elevation  myocardial  infarction
STEMI)  are  at  increased  risk  of  cardiovascular  events,  par-
icularly  death,  in  both  short-  and  long-term  follow-up.1,2
n  these  patients,  early  risk  stratiﬁcation  plays  a  central
ole,  as  the  beneﬁts  of  newer  and  more  aggressive  and
ostly  treatment  strategies  seem  to  be  proportional  to  the
M
T
tisk  of  adverse  clinical  events.  Different  scores  are  now
vailable  based  on  initial  clinical  history,  electrocardiogram,
nd  laboratory  tests,  which  enable  early  risk  stratiﬁcation
n  admission.  The  Thrombolysis  In  Myocardial  Infarction
TIMI)  score  was  developed  using  the  database  of  a  large
linical  trial  (Intravenous  nPA  for  Treatment  of  Infarcting
yocardium  Early  II).3 The  more  recent  Global  Registry  of
cute  Coronary  Events  (GRACE)  score  was  based  on  the  reg-
stry  of  the  same  name,  in  a  population  of  patients  across  the
ntire  spectrum  of  acute  coronary  syndromes  (ACS).4 Both
cores  were  developed  for  short-term  prognosis.
Although  percutaneous  coronary  intervention  (PCI)  has
igniﬁcantly  improved  the  outcome  of  patients  with  STEMI
ompared  to  ﬁbrinolytic  treatment,  high-risk  patients  still
ave  considerable  mortality  and  morbidity  and  implemen-
ation  of  new  treatment  modalities  is  highly  desirable.1,5,6
here  is  no  agreement  on  how  to  deﬁne  high-risk  patients
ith  STEMI;  different  studies  used  different  clinical  def-
nitions  and  scores  and  there  is  no  unanimity  on  which
eﬁnition  or  score  should  be  used  to  identify  a  patient’s  risk
ategory.1,7--10
The  aim  of  this  study  was  to  compare  the  performance
f  the  TIMI  and  GRACE  scores  for  risk  stratiﬁcation  of  STEMI
atients,  and  to  assess  the  feasibility  of  developing  a  simpler
odel  with  similar  predictive  performance.ethods
his  is  a retrospective  study  of  consecutive  patients  admit-
ed  to  our  intensive  care  unit  (ICU)  with  a  diagnosis  of  STEMI
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between  January  2005  and  December  2009.  Although  this
was  a  retrospective  study,  data  were  collected  prospectively
and  recorded  in  a  computer  database  of  ACS  patients  admit-
ted  to  our  institution’s  ICU  (single-center  ACS  registry).  The
inclusion  criteria  were  a  history  of  chest  pain  at  rest  or
other  symptoms  suggestive  of  an  ACS,  with  the  most  recent
episode  occurring  within  12  hours  of  admission,  associated
with  at  least  1-mm  ST-segment  elevation  in  two  or  more
contiguous  leads  or  at  least  2-mm  elevation  in  leads  V1-V4
or  new  or  presumably  new  left  bundle  branch  block  on  the
electrocardiogram  and  serial  increases  in  serum  biochemical
markers  of  cardiac  necrosis.  The  registry  enrolled  patients
treated  with  rescue  and  primary  PCI,  but  for  the  purpose
of  this  study  we  included  only  patients  who  underwent
successful  primary  angioplasty  (post-procedural  TIMI  grade
>2  ﬂow  and  <10%  diameter  stenosis  in  the  infarct-related
artery)  (98%  of  all  STEMI  patients  included  in  our  registry).
The  biomarker  used  was  cardiac  troponin  I,  with  a  thresh-
old  for  positivity  of  0.06  ng/ml.  We  evaluated  patients’
demographic  characteristics,  risk  factors  for  coronary  artery
disease,  previous  cardiac  history,  laboratory  data,  vital  signs
on  admission  and  in-hospital  treatment.  Hypertension,  dia-
betes  and  hyperlipidemia  were  deﬁned  as  either  previously
known  or  under  speciﬁc  therapy.  For  each  patient,  a  numeri-
cal  classiﬁcation  according  to  the  TIMI  and  GRACE  risk  scores
was  calculated  from  the  initial  clinical  history,  electrocar-
diogram  and  laboratory  values  collected  on  admission.3,4
The  study  endpoint  was  all-cause  mortality  in-hospital
and  at  30  days.  Follow-up  was  obtained  in  all  patients  who
survived  to  discharge  by  telephone  contact  30  days  after
admission  by  a  dedicated  follow-up  team.  Vital  status  was
available  for  99.6%  of  patients.
The  study  complies  with  the  ethical  guidelines  of  the
Declaration  of  Helsinki  and  written  informed  consent  was
obtained  from  all  subjects.
Statistical  analysis
An  exploratory  analysis  was  carried  out  for  all  variables.
Categorical  variables  were  presented  as  percentages  and
continuous  variables  as  mean  and  standard  deviation  (SD).
All  variables  used  in  the  TIMI  and  GRACE  risk  scores  were
considered  in  multivariate  analysis  and  a  new  reduced  model
was  obtained  with  the  variables  that  attained  p<0.05  in  a
backward  stepwise  logistic  regression  analysis.  In  order  to
compare  the  classical  GRACE  risk  score  with  the  reduced
model,  GRACE  score  estimates  of  probabilities  of  death  were
calculated  using  Granger’s  model  for  in-hospital  mortality4
and  a  10-fold  cross  validation  was  used  to  estimate  the  prob-
abilities  of  death  by  the  reduced  model.
Predictive  and  discriminative  abilities  were  assessed  by
the  Hosmer-Lemeshow  (HL)  test  and  by  the  area  under  the
receiver  operating  characteristic  curve  (AUC),  respectively.
The  method  described  by  DeLong  et  al.  was  used  to  compare
AUCs  from  each  of  these  models.11
Continuous  net  reclassiﬁcation  improvement  (NRI)  and
integrated  discrimination  improvement  (IDI)  were  also  cal-
culated.  The  net  proportion  of  patients  with  events,  with
higher  probabilities  of  death  (NRIevents)  and  of  patients  with-
out  events,  with  lower  probabilities  of  death  (NRInonevents),
were  calculated  using  both  models.  The  NRI  is  the  sum
w
a
i
th  STEMI  969
f  NRIevents and  NRInonevents and  quantiﬁes  the  correct-
ess  of  upward  and  downward  reclassiﬁcation  of  predicted
robabilities.12 The  IDI  is  a measure  of  improvement
n  prediction  and  may  be  viewed  as  the  difference
etween  improvement  in  average  sensitivity  and  in  aver-
ge  1-speciﬁcity.12 To  complement  this  comparative  study,
redictiveness  curves  were  also  calculated.13 The  inter-
retation  of  this  curve  is  straightforward:  a  marker  (or  a
odel)  that  is  useless  assigns  equal  risk  to  all  individuals,
nd  hence,  the  corresponding  predictiveness  curve  is  a  hori-
ontal  line  at  the  prevalence  of  the  disease;  on  the  other
and,  a  marker  (or  a  model)  that  is  highly  informative
bout  risk  yields  a  predictive  curve  that  is  close  to  a  step
unction.
Two-tailed  tests  of  signiﬁcance  are  reported.  For  all
omparisons,  a  p  value  of  <0.05  was  considered  statisti-
ally  signiﬁcant.  When  appropriate,  conﬁdence  intervals  (CI)
ere  calculated,  with  a  95%  conﬁdence  level.
The  statistical  analysis  was  carried  out  using  IBM  SPSS
tatistics,  version  19.0  (IBM  Corp.,  North  Castle,  New  York,
SA)  and  R software.14
esults
 total  of  607  consecutive  patients  were  included  in  this
tudy,  mainly  male  (76%),  with  a  mean  age  of  62  (SD=13)
ears.  The  baseline  characteristics  and  hospital  manage-
ent  are  presented  in  Table  1.  During  hospital  stay,  33
atients  died  (5.4%).  At  30-day  follow-up,  there  were  38
eaths  (6.3%).
Both  TIMI  and  GRACE  scores  showed  good  discriminatory
bility  regarding  mortality  in  short-term  follow-up.  How-
ver,  the  performance  of  the  TIMI  score  was  not  as  good
s  the  GRACE  score:  its  goodness  of  ﬁt  (predictive  ability)
as  inferior,  as  demonstrated  by  the  p  values  of  the  HL  test
Table  2).  Concerning  30-day  follow-up,  the  two  scores  were
ery  similar  in  their  predictive  performance,  but  again  the
RACE  score  was  better  at  predicting  mortality.
In  a  stepwise  multivariate  logistic  regression  analysis,  the
ost  important  independent  predictors  of  mortality  were
ge,  Killip  class  on  admission,  renal  function  and  the  occur-
ence  of  cardiac  arrest.  The  selected  variables  were  then
sed  to  built  a  new  predictive  model  for  both  in-hospital
nd  30-day  mortality  (Table  3).
Compared  to  the  GRACE  risk  score,  after  10-fold  cross
alidation,  the  reduced  model  showed  the  same  discrim-
natory  ability  (AUC=0.92  for  both,  p=0.916)  (Figure  1)
nd  better  predictive  ability  evaluated  by  goodness  of  ﬁt
p=0.138  and  p=0.802,  respectively)  and  by  calibration  plots
Figure  2).
Regarding  the  other  metrics  that  were  used  to  study
odel  improvement  (continuous  NRI  and  IDI),  reducing  the
umber  of  variables  used  to  calculate  the  GRACE  risk  score
ncreased  the  predicted  risk  of  death  in  15%  of  patients  who
ied  and  reduced  the  predicted  risk  of  death  in  49%  of  those
ho  did  not.  This  reclassiﬁcation  resulted  in  an  overall
ontinuous  NRI  of  64%.  However,  the  size  of  the  changes
as  only  signiﬁcant  for  those  with  events  (IDI=0.11),  with
 moderate  overall  IDI  of  0.103.  These  results  are  detailed
n  Table  4  and  show  a  slightly  better  performance  for
he  reduced  model.  The  comparative  study  ended  with
970  A.T.  Timóteo  et  al.
Table  1  Baseline  characteristics  and  hospital
management.
Age  (SD)  (years)  62  (13)
Male (%)  76.1
Risk factors  (%)
Hypertension  61.8
Smoking  45.0
Hyperlipidemia  51.1
Diabetes  21.9
Previous  history  (%)
MI  10.7
PCI 6.8
CABG 0.8
Stroke 4.8
On admission
HR  (SD)  (bpm)  80  (22)
Systolic  BP  (SD)  (mmHg)  130  (29)
Serum  creatinine  (SD)  (mg/dl)  1.01  (0.38)
Killip class  >1  (%) 8.2
Medical  treatment  (%)
Aspirin  98.7
Clopidogrel  98.0
ACEI 88.1
Beta-blocker  84.2
Statin 94.4
Outcome  (%)
In-hospital  mortality  5.4
30-day mortality  6.3
ACEI: angiotensin-converting enzyme inhibitor; BP: blood pres-
sure; CABG: coronary artery bypass grafting; HR: heart rate; MI:
t
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Table  2  Discriminative  ability  and  goodness  of  ﬁt  of  the
TIMI and  GRACE  risk  scores.
TIMI  GRACE
In-hospital  mortality
AUC  (95%  CI)  0.84  (0.77-0.92)  0.92  (0.87-0.96)
HL test  (p)  0.007  0.556
30-day  mortality
AUC  (95%  CI)  0.83  (0.76-0.90)  0.88  (0.82-0.95)
HL test  (p)  0.016  0.142
AUC: area under the receiver operating characteristic curve; CI:
conﬁdence interval; HL: Hosmer-Lemeshow.
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he  construction  of  a  predictiveness  plot.  Analysis  of  the
wo  curves  revealed  that  the  reduced  model  has  a  better
erformance,  as  seen  in  Figure  3:  the  reduced  model  assigns
ower  risk  to  patients  with  lower  risk  percentiles  (although
ery  slightly)  and  higher  risk  to  patients  with  higher  risk
ercentiles  (in  this  case  more  markedly).
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igure  2  Calibration  plots  for  the  simpliﬁed  model  and  the  GRA
predicted probabilities  of  death  equal  estimated  probabilities  of  deomparing  the  GRACE  risk  score  and  the  simpliﬁed  prediction
odel  (p=0.916).
iscussionffective  risk  stratiﬁcation  is  essential  in  the  management
f  patients  with  ACS.  Even  in  patients  with  STEMI,  for
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Table  3  Multivariate  logistic  regression  analysis.
OR  95%  CI  p
In-hospital  mortality
Age  (per  10-year  increment)  2.69  1.74-4.18  <0.001
Serum creatinine  (per  mg/dl  increment)  4.33  1.94-9.69  <0.001
Killip class  >1  3.44  1.28-9.23  0.014
Cardiac arrest  17.15  6.38-46.09  <0.001
30-day mortality
Age  (per  10-year  increment)  2.13  1.49-3.04  <0.001
Serum creatinine  (per  mg/dl  increment)  3.42  1.67-7.00  0.001
Killip class  >1 3.56 1.44-8.79  0.006
Cardiac arrest 10.58 4.36-25.63  <0.001
CI: conﬁdence interval; OR: odds ratio.
whom  initial  therapeutic  options  are  well-deﬁned,  patient
risk  characteristics  have  an  impact  on  early  therapeu-
tic  decision-making,  enabling  informed  decisions  regarding
additional  therapeutic  interventions.  After  reperfusion
treatment  it  is  important  to  identify  patients  at  high  risk
of  further  events,  and  hopefully  to  intervene  in  order  to
prevent  those  events.  Careful  attention  to  pivotal  factors
that  increase  the  risk  of  early  mortality  might  illuminate
the  role  of  second-tier  interventions  or  adjunctive  pharma-
cotherapy  that  would  further  lower  the  fatality  rate  of  acute
MI.  In  addition,  risk  stratiﬁcation  may  offer  the  opportunity
to  select  low-risk  patients  for  a  less  aggressive  strategy  as
well  as  for  early  hospital  discharge.  Tools  that  enhance  the
clinician’s  ability  to  rapidly  and  accurately  assess  risk  are
thus  of  substantial  interest.
Table  4  Statistics  for  model  improvement  (for  hospital
mortality)  with  the  simpliﬁed  model  after  10-fold  cross  vali-
dation  vs.  the  GRACE  risk  score.
Events  (n)  33
Nonevents  (n)  574
Continuous  NRI  (%)
NRIevents 15.2  (-18.0-49.3)
NRInonevents 48.8  (40.6-57.0)
NRI 63.9  (28.8-  99.0)
IDI statistics
IDIevents 0.1090  (0.0231-0.1949)
IDInonevents -0.0059  (-0.0120-0.0003)
IDI 0.1031  (0.0170-0.1893)
AUC
GRACE  risk  score  0.92  (0.87-0.96)
Simpliﬁed  model  0.92  (0.88-0.95)
p value  for  the  difference  0.916
Goodness  of  ﬁt  (GRACE  risk
score)a
0.138
Goodness  of  ﬁt  (simpliﬁed
model)a
0.802
95% conﬁdence intervals are shown in brackets. a Hosmer-
Lemeshow goodness of ﬁt test (p value). AUC: area under the
receiver operating characteristic curve; IDI: integrated discrim-
ination improvement; NRI: net reclassiﬁcation improvement.
The  wide  heterogeneity  among  clinical  scores  in  the
assessment  of  patients’  risk  may  be  relevant  to  the  design
of  clinical  trials  targeting  high-risk  patients.  Regarding  exist-
ing  scores,  it  has  been  shown  that  only  a  few  variables  are
needed  to  stratify  patients  with  respect  to  30-day  mortality.
However,  most  scores  still  include  more  than  ﬁve  variables,
some  with  further  complexity.
The  ideal  score  should  have  a  good  balance  between  com-
plexity  and  utility.  To  be  useful  in  clinical  practice,  a  risk
stratiﬁcation  tool  should  be  simple  and  easily  applied  at
the  bedside  and  should  make  use  of  clinical  data  that  are
routinely  available  at  hospital  presentation  and  offer  inde-
pendent  prognostic  information.  The  complexity  of  a  score  is
essentially  determined  by  factors  related  to  data  collection,
rather  than  the  methodology  involved  in  the  calculation.  In
this  regard,  the  GRACE  risk  score  has  advantages,  as  all  its
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Figure  3  Predictiveness  curves  comparing  the  GRACE  risk
score and  the  reduced  prediction  model.  The  reduced  model
correctly  assigns  lower  risk  to  patients  with  lower  risk  per-
centiles  and  higher  risk  to  patients  with  higher  risk  percentiles.
The horizontal  line  represents  the  prevalence  of  in-hospital
death (5.4%).
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was  not  possible  to  construct  a  new  score  based  on  the  pro-
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ariables  are  objective  data.  However,  when  more  variables
re  required,  this  adds  complexity  to  the  score.
This  single-center  study,  based  on  a  consecutive  STEMI
ohort,  conﬁrmed  that  the  GRACE  risk  score  is  in  some
espects  superior  to  the  TIMI  score  in  the  estimation  of
hort-term  prognosis.  This  may  be  explained  by  changes
n  the  treatment  of  STEMI  patients  over  time.  Modest
ncreases  in  the  use  of  aspirin,  clopidogrel,  glycoprotein
Ib/IIIa  inhibitors  and  low  molecular  weight  heparin  (instead
f  unfractionated  heparin)  have  been  seen  in  recent  years,
articularly  in  STEMI  patients,  likely  in  part  accounted  for
y  an  increase  in  the  use  of  primary  PCI  instead  of  ﬁbri-
olysis  as  reperfusion  therapy.15 There  has  also  been  a
ownward  trend  in  the  frequency  of  bleeding16:  although
he  frequency  of  major  bleeding  would  be  expected  to  have
ncreased  over  time  as  a  result  of  more  potent  combina-
ions  of  antithrombotic  therapies  and  greater  use  of  cardiac
atheterization  and  PCI,  the  opposite  is  found.  This  may
e  due  to  changes  in  contemporary  clinical  practice,  and
ay  have  implications  for  mortality.  Nevertheless,  when
ajor  bleeding  occurs,  it  is  associated  with  a  greater  risk
f  death.  The  TIMI  score  for  STEMI  was  developed  for
isk  stratiﬁcation  in  the  era  of  thrombolytic  reperfusion
herapy3 and  not  in  the  context  of  contemporary  treat-
ent,  in  which  PCI  (mechanical  reperfusion)  is  the  mainstay
f  treatment  and  new  antithrombotic  agents  are  available.
his  may  be  why  the  TIMI  score  showed  lower  predictive
ccuracy.
On  the  other  hand,  although  the  GRACE  database  is  more
ecent,  only  74.2%  of  its  STEMI  patients  presenting  to  the
ospital  within  12  hours  of  symptom  onset  received  reper-
usion  therapy  and,  of  these,  only  30.2%  underwent  primary
CI.15 A  third  of  patients  who  appeared  to  be  otherwise
ligible  received  no  reperfusion  therapy  and  only  a third
eceived  such  therapy  within  the  guideline-recommended
argets  of  30  and  90  minutes  for  thrombolysis  and  primary
CI,  respectively.15 The  GRACE  registry  also  showed  that
atients  admitted  to  a  hospital  with  catheterization  facil-
ties  were  more  likely  to  undergo  intervention,  which  may
xplain  the  higher  risk  of  death  within  six  months  of  dis-
harge  observed  in  these  patients;  this  may  be  partly  due
o  the  bias  of  referral  of  patients  in  worse  clinical  condi-
ion  to  tertiary  centers,  but  also  to  hazards  related  to  the
ntervention.15,17
The  relative  performance  of  the  different  risk  scores
an  also  be  explained  by  their  composition.  The  TIMI  risk
core  includes  age  as  a  categorical  variable,  unlike  the
RACE  score.  This  approach  may  miss  the  continuous  pro-
nostic  value  observed  over  the  entire  spectrum  of  age.
he  TIMI  risk  score  also  does  not  take  into  account  renal
unction,  which  is  one  of  the  most  important  predictors  of
utcome.
In  our  population,  multivariate  logistic  regression  anal-
sis  identiﬁed  age,  as  a  continuous  variable,  heart
ailure  on  admission  and  baseline  serum  creatinine  as
he  most  signiﬁcant  predictors  of  prognosis,  together
ith  cardiac  arrest.  Serum  creatinine  has  only  more
ecently  been  identiﬁed  as  a  powerful  risk  variable,  as
t  was  not  generally  included  in  ACS  databases  before
000.18
After  an  internal  10-fold  cross  validation,  it  was  shown
hat  it  is  possible  to  obtain  a  simpliﬁed  reduced  prediction
p
p
i
uA.T.  Timóteo  et  al.
odel  with  only  four  variables  that  maintains  the  same
iscriminative  ability  and  with  a  slightly  better  predictive
erformance.
In the  present  study,  other  traditional  risk  markers  were
ot  signiﬁcant  predictors  of  outcome.  This  may  be  related
o  the  more  aggressive  invasive  management  adopted
n  these  high-risk  patients,  since  all  patients  underwent
uccessful  primary  angioplasty  in  the  ﬁrst  12  hours  of
TEMI.  By  contrast,  studies  that  demonstrated  the  progno-
tic  value  of  other  variables  such  as  cardiac  biomarkers
sed  peak  instead  of  baseline  levels  as  analyzed  in  our
tudy.
We  chose  to  study  this  speciﬁc  patient  population
ecause  of  the  considerable  heterogeneity  found  in  ACS
opulations,  which  differ  in  type  of  medical  treatment,
se  of  PCI  or  ﬁbrinolysis,  and  mortality.  These  differ-
nces  make  it  difﬁcult  to  determine  the  applicability  of
isk  scores  to  these  differing  populations.  STEMI  patients
re  a  high-risk  cohort  of  ACS  patients,  with  the  high-
st  mortality.  We  analyzed  patients  undergoing  successful
rimary  PCI  to  obtain  a  more  homogeneous  population,
ince  other  patients  have  different  baseline  characteris-
ics  and  different  treatment  management  and  a  worse
rognosis.  For  this  reason,  our  study  evaluated  only  pri-
ary  PCI  patients,  reﬂecting  the  contemporary  treatment
f  STEMI  in  a  more  homogeneous  population.  In  these
atients,  risk  stratiﬁcation  is  more  important,  particu-
arly  in  the  selection  of  new  therapies  to  improve  their
rognosis,  which  is  ominous,  with  in-hospital  mortality
f  >5%.15
imitations
his  is  a  relatively  small  sample,  and  the  fact  that  it  is  a
ingle-center  study  may  limit  our  conclusions.  Moreover,  the
esults  only  apply  to  STEMI  patients  undergoing  successful
rimary  PCI.
Because  the  GRACE  risk  score  was  developed  for  predic-
ion  of  hospital  mortality,  no  further  comparisons  were  made
egarding  30-day  mortality.
It  is  also  important  to  determine  whether  the  validity  of
his  new  model  seen  for  short-term  follow-up  is  maintained
n  medium-term  follow-up  (one  year).
onclusions
f  the  classical  scores  available  for  risk  stratiﬁcation  after
TEMI  and  in  the  contemporary  era  of  treatment,  the  GRACE
isk  score  has  the  highest  predictive  accuracy.  It  is,  however,
ossible  to  simplify  current  scores  after  STEMI  and  primary
ngioplasty  with  only  four  variables  (age,  serum  creatinine
n  admission,  heart  failure  on  admission  and  the  occurrence
f  cardiac  arrest).  This  simpliﬁed  model  maintained  good
redictive  ability  for  short-term  mortality  compared  to  more
omplex  risk  scores.  Due  to  our  relatively  small  sample,  itosed  simpliﬁed  model.  However,  this  study  supports  the
ossibility  that  such  a  simpliﬁed  score  could  be  constructed
f  a much  larger  sample  (such  as  from  a  large  registry)  were
sed.
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